Understanding anti-leukemia responses to donor lymphocyte infusion

DSpace/Manakin Repository

Understanding anti-leukemia responses to donor lymphocyte infusion

Citable link to this page

 

 
Title: Understanding anti-leukemia responses to donor lymphocyte infusion
Author: Bachireddy, Pavan; Wu, Catherine J

Note: Order does not necessarily reflect citation order of authors.

Citation: Bachireddy, Pavan, and Catherine J Wu. 2014. “Understanding anti-leukemia responses to donor lymphocyte infusion.” Oncoimmunology 3 (1): e28187. doi:10.4161/onci.28187. http://dx.doi.org/10.4161/onci.28187.
Full Text & Related Files:
Abstract: Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti-leukemia immunity.
Published Version: doi:10.4161/onci.28187
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203631/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:14351312
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters